6505--VA San Diego PSMA
Veterans Affairs · 262-NETWORK CONTRACT OFFICE 22 (36C262)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26226Q0580 in this department, oldest first.
- Apr 1, 2026Combined Synopsis/SolicitationOpen
- Apr 22, 2026 · this noticeAward NoticeTELIX PHARMACEUTICALS US INC · $496K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
The total contract value including base plus option four year is $4,557,000.00.
Who won similar work
27 award notices on SAM.gov in the last 24 months. Matched by: Same office (262-NETWORK CONTRACT OFFICE 22 (36C262)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (27): middle half $583K to $3.6M, median $1.8M; range $53K to $37.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| EXELAN PHARMACEUTICALS INC | 9 | $42.2M | Jan 28, 2026 |
| RLS (USA) INC. | 4 | $9.6M | Mar 5, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $226.8B | 4 | $929K | Oct 1, 2026 |
| Novartis Pharmaceuticals Corporation | 2 | $8.9M | Jan 8, 2026 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | 2 | $6.4M | Dec 16, 2024 |
| BOSTON SCIENTIFIC CORP · $BSX · $14.2B | 2 | $1.4M | Dec 23, 2025 |
| PROGENICS PHARMACEUTICALS INC | 2 | $1.2M | Aug 21, 2025 |
| SIRTEX MEDICAL INC | 1 | $37.3M | Nov 12, 2025 |
| Bristol-Myers Squibb Company | 1 | $364K | Jun 30, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $226.8B revenue in FY2026. The median single-winner award in these 27 past awards, $1.8M, is under 0.1% of that. 10-K
- $BSX reported $14.2B revenue in FY2025. The median single-winner award in these 27 past awards, $1.8M, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026CARDINAL HEALTH 414, LLC$53K6505--VALL Iodine Isotope IDIQ
- Jun 30, 2026Bristol-Myers Squibb Company$364K6505--Emergency Breyanzi
- Mar 18, 2026CARDINAL HEALTH 414, LLC$259K6505--VA San Diego and Phoenix Lymphoseek IDIQ
- Mar 5, 2026RLS (USA) INC.$752K6505--VA Tucson Radiopharmaceuticals Base DO
- Mar 5, 2026RLS (USA) INC.$1.6M6505--VA Phoenix Radiopharmaceuticals Base DO
- Feb 24, 2026RLS (USA) INC.$7.0M6505--VA Phoenix and Tucson Radiopharmaceuticals IDIQ
- Jan 28, 2026EXELAN PHARMACEUTICALS INC$3.3M6505--VA San Diego Lenalidomide DO
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$3.7M6505--VA Long Beach Lenalidomide DO
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$2.1M6505--VA Albuquerque Lenalidomide DO
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$2.1M6505--VA Loma Linda Lenalidomide DO
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (10 filings)
- 1 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $63K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 3 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 5 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.